3.8 Article

The intrasulcular application effect of bisphosphonate hydrogel toward osteoclast activity and relapse movement

期刊

SAUDI DENTAL JOURNAL
卷 33, 期 5, 页码 292-298

出版社

ELSEVIER
DOI: 10.1016/j.sdentj.2020.03.003

关键词

Risedronate; Controlled release; Gelatin hydrogel; Orthodontics; Relapse movement

资金

  1. Directorate General of Higher Education (DIKTI) of the Ministry of Education and Culture of the Republic of Indonesia

向作者/读者索取更多资源

The controlled release of bisphosphonate risedronate with gelatin hydrogel as a carrier has shown efficacy in decreasing tooth relapse movement and osteoclast activity.
Introduction: Orthodontic relapse occurs after orthodontic treatment and shifting of teeth to unfavorable positions. Bisphosphonates' effects on bone resorption and relapse prevention have been extensively investigated. However, topical administration, which results in local effect, is still a problem. Objective: This study aimed to investigate the effect of risedronate with gelatin hydrogel as a carrier to prevent relapse movement by inhibiting osteoclast activity. Methods: Lower incisors of 75 guinea pigs were moved distally using an orthodontic appliance until +/- 3 mm length. Gelatin hydrogel was fabricated to obtain a semisolid controlled release of 250 (Bis-CR250) and 500 mmol/L risedronate (Bis-CR500) and then applied intrasulcularly into the mesial subperiosteal area of 50 guinea pigs (25 in each group) every 3 days; the rest were the control (Bis-CR000). After 14 days of stabilization, the apparatus was removed. The distance decrease between incisors and the osteoclast number with TRAP staining at 0, 3, 7, 14, and 21 days were measured. ANOVA was used to determine the differences among the different time and experimental groups. Results: Both treatments showed significantly less relapse movement compared to the control (p < 0.05) at 14 and 21 days. Bis-CR500 more effectively inhibited the relapse movement than Bis-CR250 on day 21, indicating a dose dependency in the inhibition. Both treatments showed less osteoclast numbers than control (p < 0.05). Conclusion: Controlled release of bisphosphonate risedronate with a topically administered gelatin hydrogel has shown to be effective in decreasing the tooth relapse movement and osteoclast activity. (C) 2021 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据